Using MRI to predict disability progression in multiple sclerosis patients
Official title: Evaluation of MRI Biomarkers Predictive of Disability Progression in Patients With Multiple Sclerosis
Run by Poitiers University Hospital · NCT05491031 · Data updated 2026-11-12
This study is testing whether advanced MRI scans can help predict if people with relapsing-remitting multiple sclerosis will develop a more serious form of the disease.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | Poitiers University Hospital Academic / other |
| Locations | 1 site (Poitiers) |
| Status | Recruiting |
| Started | April 25, 2023 |
| Main results expected | May 1, 2030 |
| Study ends | May 1, 2030 |
| Registry record updated | May 5, 2026 |
| Trial ID | NCT05491031 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18 and older with a history of multiple sclerosis lasting up to 25 years and irreversible disability rated at 7 or lower on the EDSS scale.
✕Probably not a fit
Patients with other progressive neurological diseases or those who are illiterate and non-French speaking may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to identify MRI biomarkers that can predict the transition from relapsing-remitting multiple sclerosis (RRMS) to secondary progressive multiple sclerosis (SPMS). By utilizing ultra-high field 7T magnetic resonance spectroscopy, the study seeks to enhance the visualization of chronic inflammatory lesions and measure brain atrophy with greater precision. The research focuses on analyzing cerebral metabolites to gain insights into cellular energy metabolism and neurodegeneration. This approach could potentially reduce the diagnostic uncertainty associated with SPMS.
Why it matters
Potential benefit: If successful, this study could lead to earlier and more accurate diagnosis of disability progression in multiple sclerosis patients.
How similar studies have gone: While the use of advanced MRI techniques in multiple sclerosis is promising, this specific approach using ultra-high field 7T MRI for predictive biomarkers is relatively novel and has not been extensively tested in prior studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 18 years, * Duration of disease ≤ 25 years, * Irreversible disability ≤ 7 (permanent wheelchair use) on the EDSS scale Exclusion Criteria: * Other progressive neurological disease, * Isolated radiologic syndrome (RIS), * Severe psychiatric pathology not in balance, * Change in dosage, discontinuation or initiation of a psychotropic treatment within the last month, * Change in background MS treatment for less than 3 months, * A course of corticosteroids (oral or intravenous) for less than one month, * Patient with a contraindication to MRI: pregnancy, metallic ocular foreign body (accidental splinters or others), pacemaker, implantable defibrillator, neurostimulator not compatible with MRI 7.0 T, cochlear implants and in general any electronic medical equipment implanted in an irremovable way: metallic cardiac valve, vascular clips (formerly implanted on cranial aneurysm), metallic prosthesis...), * Illiterate and non-French speaking patient: patient who is partially or completely unable to read and write French. * Patient benefiting from reinforced protection, i.e. minor, subject deprived of liberty by a judicial or administrative decision, subject staying in a health or social establishment, adult under legal protection and finally patient in emergency situation, * Pregnant or breastfeeding women, women of childbearing age who do not have effective contraception (hormonal/mechanical: per os, injectable, transcutaneous, implantable, intrauterine device, or surgical: tubal ligation, hysterectomy, total oophorectomy)
Where it's running
-
PoitiersUH
Poitiers, France Recruiting
Study contacts
- Study coordinator: Amelie Dos Santos, Dr
- Email: amelie.dos-santos@chu-poitiers.fr
- Phone: +33.5.49.44.44.46
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Treadmill-based virtual reality walking training for MS patients
This study tests whether a treadmill with virtual reality and smart socks can help people with multiple sclerosis walk better and feel safer in daily life.
-
Virtual Reality and Mental Practice to Improve Balance and Walking in Relapsing MS
This study tests whether virtual reality training or mental practice can improve balance and walking in people with relapsing–remitting multiple sclerosis.
-
REAL-MS: A Look at Autologous Stem Cell Transplant vs High-Efficacy MS Therapies in Real-World Care
This study tests how AHSCT compares to high-efficacy MS medicines in adults treated in routine clinical care.
-
Tolebrutinib in real-world MS care for patients treated by clinicians
This real-world study sees how tolebrutinib is used for multiple sclerosis patients and what outcomes look like in everyday practice.
-
Pilates via live video vs. prerecorded videos for people with multiple sclerosis
This study tests whether live, coach-led Pilates sessions through video calls are more beneficial than prerecorded Pilates videos for adults with MS.
-
Cooling During Inpatient Rehab for People with MS
This trial tests whether wearing a cooling vest during intensive training can reduce fatigue and improve walking, strength, balance, and cognition in people with multiple sclerosis during a 3-week inpatient rehab stay.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.